Study ID | Intervention(s) and comparator(s) | Participants included in analysis (N) | Participants with a specific adverse event (description) | Participants with at least one specific adverse events (N) | Participants with at least one specific adverse event (%) |
Timmers 2016 | I: trans‐resveratrol + oral hypoglycaemic agent(s) or diet alone | 17 | 0 | 0 | 0 |
C: placebo + oral hypoglycaemic agent(s) or diet alone | 17 | 0 | 0 | 0 | |
Thazhath 2016 | I: resveratrol | 14 | 0 | 0 | 0 |
C: placebo | 14 | 0 | 0 | 0 | |
Brasnyo 2011 | I: trans‐resveratrol | 10 | 0 | 0 | 0 |
C: placebo | 9 | 0 | 0 | 0 | |
— denotes not reported. C: comparator, I: intervention. |